- Home
- MAC vs INSP Comparison
MAC vs INSP Comparison
Compare MAC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAC
- INSP
- Stock Information
- Founded
- MAC 1964
- INSP 2007
- Country
- MAC United States
- INSP United States
- Employees
- MAC N/A
- INSP N/A
- Industry
- MAC Real Estate Investment Trusts
- INSP Medical/Dental Instruments
- Sector
- MAC Real Estate
- INSP Health Care
- Exchange
- MAC Nasdaq
- INSP Nasdaq
- Market Cap
- MAC 4.0B
- INSP 4.6B
- IPO Year
- MAC 1994
- INSP 2018
- Fundamental
- Price
- MAC $16.64
- INSP $131.98
- Analyst Decision
- MAC Hold
- INSP Buy
- Analyst Count
- MAC 11
- INSP 12
- Target Price
- MAC $18.40
- INSP $213.75
- AVG Volume (30 Days)
- MAC 1.6M
- INSP 560.7K
- Earning Date
- MAC 07-30-2025
- INSP 08-05-2025
- Dividend Yield
- MAC 4.09%
- INSP N/A
- EPS Growth
- MAC N/A
- INSP N/A
- EPS
- MAC N/A
- INSP 2.17
- Revenue
- MAC $1,012,216,000.00
- INSP $840,111,000.00
- Revenue This Year
- MAC $8.50
- INSP $20.61
- Revenue Next Year
- MAC N/A
- INSP $17.32
- P/E Ratio
- MAC N/A
- INSP $59.30
- Revenue Growth
- MAC 20.66
- INSP 27.11
- 52 Week Low
- MAC $12.48
- INSP $123.00
- 52 Week High
- MAC $22.27
- INSP $225.00
- Technical
- Relative Strength Index (RSI)
- MAC 59.42
- INSP 38.33
- Support Level
- MAC $15.88
- INSP $126.93
- Resistance Level
- MAC $16.73
- INSP $134.17
- Average True Range (ATR)
- MAC 0.49
- INSP 4.69
- MACD
- MAC 0.04
- INSP 0.65
- Stochastic Oscillator
- MAC 96.83
- INSP 36.42
About MAC Macerich Company (The)
Macerich invests in premium mall assets. The company owns 30 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with two power centers and seven other real estate assets. The company's total portfolio has 42.9 million square feet of gross leasable area and averaged $837 sales per square foot over the 12 months ended in December 2024.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.